As associate chief counsel for enforcement in US FDA’s Office of Chief Counsel, Beth Weinman helped to investigate potential criminal violations of the Food Drug and Cosmetic Act. She worked on qui tam False Claims Act whistleblower investigations involving the US Department of Health and Human Services, the Department of Justice and other agencies across the federal government.
After more than seven years at the agency, Weinman left government last month to join Ropes & Gray’s life sciences and FDA regulatory law practice. Medtech Insight spoke with Weinman...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?